Navigation Links
Quantification of the Purinergic Receptor P2X3 using ICAT and ,,, Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer

David Barnidge, Leo E. Bonilla, Gargi Choudhary

Neuromics, Inc., Minneapolis, MN
Thermo Finnigan, San Jose, CA

ICAT Analysis

The data presented here was acquired using the ProteomeX integrated proteomics workstation. Overview The differential quantification of the purinergic receptor P2X3 in membrane preparations of kidney cells is demonstrated using a fully integrated 2D LC-MS/MS system to detect and quantify ICAT-labeled tryptic peptides. Optimization of ICAT procedures, by removal of the need for off-line ion exchange (IEX) and affinity clean-up after ICAT derivatization, is demonstrated. Introduction The systematic identification and quantification of the constitutive proteins in a complex system (e.g., organelle, cell, tissue) is the central task of proteomics. Orthogonal two-dimensional chromatography (2D-LC) coupled with tandem mass spectrometry (MSn) represents a powerful technology platform for the global study of proteomes.(1) Stable-isotope labeling, such as isotope-coded affinity tags (ICAT), allows the implementation of MS-based methods for quantitative protein profiling.

The ICAT procedure relies on the selective alkylation of the free thiol groups of cysteines with either a d0- or d8- ICAT followed by proteolysis, affinity enrichment of the labeled peptides, and MS analysis.(2) Quantitative ICAT labeling of membrane proteins remains an imp
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Quantification made easy
2. Quantification of siRNA Silencing Efficiency Using the LightCycler System
3. Gene-Expression Analysis of TP, DPD, and TS Using the LightCycler mRNA Quantification KitsPLUS
4. Quantification of Nucleosomes in Serum by the Cell Death Detection ELISAplus
5. Real-Time Quantification of Genomic DNA Using DyNAzyme II DNA Polymerase and SYBR Green I Dye
6. DNA Damage and Repair - Quantification of Sub-Cellular Events Using Automated Confocal Imaging
7. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
8. Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived Tissue
9. pFB-ERV: Retroviral Delivery of the Ecdysone Receptor Proteins
10. Gene-Specific Primers for NMDA Receptor Subunits
11. TKB1 Cells Identify Receptor Tyrosine Kinase Interacting Proteins

Post Your Comments:
(Date:11/20/2009)..., SAN DIEGO, Nov. 20 Veridiam (ww...in the mid-size company category at the 2009 Workp...y the San Diego Society for Human Resources Manage...n resources practices. ,, Veridiam was one of n...nominated companies, honored at the recent awards ...
(Date:11/20/2009)... , STOCKHOLM, November 20 ... European Investment Fund (EIF) has entered into a...investment fund will be,managed by Karolinska Deve...lio of early-stage pharmaceutical and medical tech...Euros in the co-investment fund. The agreement,rep...
(Date:11/20/2009)... METTLER TOLEDO recently announce...webinar, “The Role of Process Analytical Tec...ring” on December 1, 2009. , ... The Role of Process Analytical Technology (PAT) i...n December 1, Process Analytical Technology (PAT) ...
(Date:11/19/2009)..., SEATTLE, Nov. 19 Omer...audited financial results for the third quarter en... September 30, 2009, Omeros reported a net loss of...a net loss of $7.4 million, or $2.54 per share, fo...ed September 30, 2009, the Company reported a net ...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
...research may have come up with an explanation as t...d rocks. This explanation could turn out to be the...production techniques with the intent of increasin...arch group at the Nano-Science Center, part of the...n has investigated drill cores collected from Nort...
..., May 11 Sanofi-aventis U.S. announced today that...ma plc the U.S. commercial rights to Oforta(TM) (f... B-cell chronic lymphocytic leukemia (CLL) drug. ... for use as a second-line therapy to treat adults ...to add Oforta to our existing oncology portfolio, ...
...May 11 Pharmasset, Inc. (Nasdaq: VRUS ), a clin...covering, developing, and commercializing novel dr...results and operational highlights for the fiscal ...ults , , Revenues were $1.9 million during the q...on for the quarter ended March 31, 2008 and reflec...
Other Biology Technology:New Danish research shows how oil gets stuck underground 2Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment 2Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment 3Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 2Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 3Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 4Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 5Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 6Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 7Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 8
(Date:11/23/2009)...l Medical Sciences (NIGMS), part of the National I...ion for grants in scientific areas it identified a... grant program to stimulate biomedical research an... Recovery and Reinvestment Act (Recovery Act). , ... a significant impact on a field of biomedical sci...
(Date:11/23/2009)...rector of the Interuniversity Professorship in Law...e University of the Basque Country. The Professors...er experts such as researchers in the fields of mo...ethics. , The Interuniversity Professorship in L...usto and the Basque Country was created in 1993. T...
(Date:11/23/2009)...erman . , Of all global carbon dioxide emiss...where it contributes to global warming. The remain...stems such as forests, grasslands and peat-lands. ...restrial ecosystems is considered one of the main,...ange. However, new greenhouse gas bookkeeping has ...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2Intensive land management leaves Europe without carbon sinks 2Globus Medical Announces Launch of COALITION 28TM 29 ACDF Spacer System 47604 1Globus Medical Announces Launch of COALITION 28TM 29 ACDF Spacer System 47604 2EXTRA TV Features Tosca Renos Eat Clean Diets Libido Boosting Foods 47600 1EXTRA TV Features Tosca Renos Eat Clean Diets Libido Boosting Foods 47600 2Genomatica Produces Pure BDO From Natural Sugars 12413 1Genomatica Produces Pure BDO From Natural Sugars 12413 2Genomatica Produces Pure BDO From Natural Sugars 12413 3Genomatica Produces Pure BDO From Natural Sugars 12413 4
...ll needs both to build new and to degrade old or d...ntracellular systems work in concert to keep the c...eins. When proteins or peptides mutate, they can p...tracellular environment. In Huntington,s disease (...in gene eventually causes the cell to build up int...
...cientists has announced a major expansion of a lin...s in living organisms. The expansion provides ter... events that occur when a pathogenic or beneficial...events is crucial for developing new interventions...obes while preserving or encouraging the presence ...
...they won,t be able to understand the brain until t...how billions of neurons are interconnected. Now, r...udies have jumped what many believe to be a major ... the connections to a single neuron. , In the Marc...escribe how they modified the deadly rabies virus,...
Other Biology News:Proteasome activator enhances survival of Huntington's disease neuronal model cells 2Uniform language for describing genes of pathogenic and beneficial microbes 2Uniform language for describing genes of pathogenic and beneficial microbes 3Deconstructing brain wiring, one neuron at a time 2Deconstructing brain wiring, one neuron at a time 3
5X StabilCoat Immunoassay Stabilizer from SurModics, Inc.
...llow crystalline solid. PROTECT FROM LIGHT. Useful...response data are not required. Purity: ≥98% b...us systems, preparation of a 10 mM stock in DMSO i... can be added to H 2 O with rapid mixing (e.g. 10 ...
Mouse Anti-Fatty Acid Binding Protein (FABP) Antibody, TRITC (Rhodamine) Conjugated from HyTest Ltd.
Mouse Anti-Rhodopsin Monoclonal Antibody, Unconjugated, Clone RET-P1 from GeneTex
Biology Products: